Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.75 USD | -0.96% | -4.18% | -16.16% |
05-10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
05-08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |